Story thread · 2 reports / 2 sources
New Cholesterol Drugs Move Closer to EU Approval
medscape.com · 15d
CHMP has recommended Lyrokaul, Evlarco, and Ubeslo, potentially expanding nonstatin options for patients who remain above LDL-C goals. Medscape News Europe
First report: CHMP backs obicetrapib for cholesterol treatment in Europe — investing.com, 18d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.